🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Eva Ciruelos

Research Institute Hospital 12 de Octubre

ORCID: 0000-0002-2796-1042

Also affiliated with Hospital Universitario 12 De Octubre

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Figure S1 from A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor–positive HER2-negative Breast Cancer

10.1158/1078-0432.22477262
Top 100%
0DataRank
Top 100%0 citations

Yi-Hsuan Tsai, Tomás Pascual, Laia Paré, Barbara Adamo, María Vidal +8 more

Papers

Driven by 10 papers — median percentile 0. Top paper: “Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer”.

Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3953
N/A
3.2DataRank · unranked
108 citations

Kenji Tamura, Mafalda Oliveira, Eva Ciruelos, Ingrid A. Mayer, Marie‐Paule Sablin +23 more

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer

Breast Cancer Research(2020)10.1186/s13058-020-01354-y
N/A
3.0DataRank · unranked
148 citations

Cristina Saura, Romualdo Barroso‐Sousa, Hao Guo, Eva Ciruelos, Begoña Bermejo +18 more

Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

Journal of Clinical Oncology(2022)10.1200/jco.22.01065
N/A
2.2DataRank · unranked
59 citations

Gini F. Fleming, István Láng, Eva Ciruelos, Hervé Bonnefoi, Meritxell Bellet +22 more

A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

The Lancet Oncology(2020)10.1016/s1470-2045(20)30450-2
N/A
0.650DataRank · unranked
75 citations

Valentina Guarneri, Laia Paré, Gaia Griguolo, Tomás Pascual, Maria Vittoria Dieci +34 more

Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B)

ESMO Open(2024)10.1016/j.esmoop.2024.102388
N/A
0.442DataRank · unranked
18 citations

Tomás Pascual, Fara Brasó‐Maristany, Laia Paré, Olga Martínez‐Sáez, Javier Cortés +15 more

Clinical utility of a novel non-invasive technology for monitoring severe neutropenia in anticancer therapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13632
N/A
0.104DataRank · unranked
1 citations

Toshiaki Iwase, Pablo Tolosa, Pablo Justo Jiménez, Antonia Rodríguez Izquierdo, Tycho Baumann +15 more

Genomic characterisation of hormone receptor-positive breast cancer arising in very young women

Annals of Oncology(2023)10.1016/j.annonc.2023.01.009
N/A
0DataRank · unranked
48 citations

Giuseppe Viale, Serena Nik‐Zainal, Peter Savas, Roswitha Kammler, Patrizia Dell’Orto +33 more

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.40931
N/A
0DataRank · unranked
2 citations

Yue Ren, Yi Zhang, Natalia Siuliukina, Catherine A. Schnabel, Roswitha Kammler +27 more

Figure S4 from A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor–positive HER2-negative Breast Cancer

10.1158/1078-0432.22477253
N/A
0DataRank · unranked
0 citations

Yi-Hsuan Tsai, Tomás Pascual, Laia Paré, Barbara Adamo, María Vidal +8 more

Figure S1 from A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor–positive HER2-negative Breast Cancer

10.1158/1078-0432.22477262
Top 100%
0DataRank
Top 100%0 citations

Yi-Hsuan Tsai, Tomás Pascual, Laia Paré, Barbara Adamo, María Vidal +8 more